Results 61 to 70 of about 380,384 (208)

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Concomitant medications (CMs) influence outcomes in patients receiving immune checkpoint inhibitors (ICIs), but their impact in sarcoma remains undefined. We assessed the association between CM use and ICI outcomes in patients with advanced or metastatic sarcoma. Methods This pooled analysis included patients from seven investigator‐
Adel Shahnam, Kristen DiConza, Simran Jasnani, Rhoena Desir‐Camille, Evan Rosenbaum, Olayode Babatunde, Ciara M. Kelly, Lauren B. Banks, Viswatej Avutu, Ping Chi, Sujana Movva, Mark A. Dickson, Mrinal M. Gounder, Mary L. Keohan, Robert G. Maki, William D. Tap, Sandra P. D'Angelo   +16 more
wiley   +1 more source

Cystosarcoma phyllodes A malignant cystosarcoma phyllodes in a 14-year-old girl

The Turkish Journal of Pediatrics, 1986
The case of a 14-year-old girl with a malignant cystosarcoma phyllodes is presented. The lesion had grown rapidly and metastasized to the axillary lymph nodes, lung, bone and liver.
D Oğün, O Günhan, F Göze
openaire   +3 more sources

Beyond the Triple‐Negative Label: A Case Report on Metaplastic Breast Carcinoma

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Metaplastic breast carcinoma (MpBC) is a rare, aggressive breast malignancy with poorer prognosis than conventional subtypes. Predominant hematogenous spread, frequent triple‐negative phenotype, chemoresistance, rarity, and poorly defined treatment protocols render MpBC a significant diagnostic and therapeutic challenge for oncologists in ...
Samana Oli, Ayush Sapkota, Sajjad Ahmed Khan, Asmita Rayamajhi, Dhiraj Gupta, Vivek Ghosh, Diksha Karki, Rikesh Acharya, Prajina Shrestha   +8 more
wiley   +1 more source

Distribution of elasticity score for benign, borderline and malignant phyllodes tumors.

, 2014
Distribution of elasticity score for benign, borderline and malignant phyllodes tumors.
Xin-Bao Zhao (509551), Hai-Yun Yang (509553), Bing Ou (509548), Xiao-Yun Xiao (509549), Wen-Jing Zhong (509550), Zi-Zhuo Zhao (509552), Hui Zhi (106532), Lu-Jing Li (509547), Hong Zeng (24161), Bao-Ming Luo (300891)   +9 more
core   +1 more source

B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration

Tumor Biology, 2018
Phyllodes tumors are rare biphasic breast tumors with the potential for both local recurrence and distant metastasis. The aberrant expression of B7-H3 and B7-H4 B7 molecules could be potential targets for future development of immunotherapeutic ...
Ga-Eon Kim, Nah Ihm Kim, Min Ho Park, Ji Shin Lee   +3 more
doaj   +1 more source

Rapidly progressing malignant phyllodes tumor of the prostate with normal prostate-specific antigen levels: A case report

Indian Journal of Pathology and Microbiology, 2020
Malignant phyllodes tumor of the prostate is a very rare entity. Here, we describe a 51-year-old patient with a malignant phyllodes tumor of the prostate with a poor prognosis and normal prostate-specific antigen levels.
Xiaorong Zhang, Jiali Hu, Xiao Xu, Lin Cheng   +3 more
doaj   +1 more source

Granulocyte-colony stimulating factor-producing malignant phyllodes tumor of the breast: a rare case

Surgical Case Reports, 2021
Background Granulocyte-colony stimulating factor (G-CSF)-producing tumors can cause leukocytosis despite an absence of infection. G-CSF-producing tumors have been reported in various organs such as the lung, esophagus, and stomach but rarely in the ...
Kimihisa Mizoguchi, Kazuhisa Kaneshiro, Makoto Kubo, Yoshihiko Sadakari, Yoshizo Kimura, Koichi Higaki, Toshiro Ogata, Masahiko Taniguchi   +7 more
doaj   +1 more source

Prostatic stromal tumors with uncertain malignant potential: A scoping review of clinical challenges and management strategies

UroPrecision, Volume 4, Issue 2, Page 88-97, June 2026.
Abstract Prostatic stromal tumor of uncertain malignant potential (STUMP) is a rare neoplasm arising from specialized prostatic stromal cells with a broad range of histologic patterns and unpredictable clinical behavior. It is often challenging to distinguish STUMP from prostatic stromal sarcoma due to morphological similarities, necessitating specific
Ibrahim A. Khalil, Abdullah M. Al‐Jubouri, Khaled Murshed, Ahmad R. Al‐Qudimat, Majd Alkabbani, Nagy Younes, Khalid Al Jalham, Khalid Al Rumaihi   +7 more
wiley   +1 more source

Malignant Phyllodes Tumors with Heterologous Differentiation - Two Interesting Cases

Journal of Medical Sciences and Health
Malignant phyllodes tumors represent rare but potentially aggressive form of breast neoplasm, comprising 0.3 to 0.9% of primary breast tumors. They infrequently exhibit heterologous mesenchymal differentiation. Here, we present two atypical cases of
Fatema Topiwala, Jyoti Gorade, Tulsi Chhadi, Satish Helwatkar   +3 more
doaj   +1 more source

Myxoid Liposarcoma of the Breast Mimicking Phyllodes Tumor: A Case Report

Journal of the Korean Society of Radiology, 2023
Myxoid liposarcoma is an extremely rare malignant breast tumor. We report the case of a 44-year-old woman who had myxoid liposarcoma of the breast with a history of phyllodes tumor and describe the imaging findings on US, mammography, and MRI.
Se Jin Lee, Jung Kyu Ryu, Kyu Yeoun Won, Sang-Ah Han   +3 more
doaj   +1 more source